- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05110872
Cigarette and E-cigarette Flavors Manipulations in the Experimental Tobacco Marketplace
September 23, 2025 updated by: Roberta Freitas-Lemos, Virginia Polytechnic Institute and State University
COMET Study 2: Effects of Cigarette and E-cigarette Flavor Restrictions on Cigarette Demand and Substitution in the Experimental Tobacco Marketplace
This is a one-session study that participants complete remotely including consent, Experimental Tobacco Marketplace purchases, and assessments to examine the effects of cigarette and e-cigarette flavors on cigarette demand and substitution in the Experimental Tobacco Marketplace.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
- Behavioral: Cigarette flavor restricted and e-cigarette flavor restricted
- Behavioral: Cigarette flavor restricted and e-cigarette flavor unrestricted
- Behavioral: Cigarette flavor unrestricted and e-cigarette flavor restricted
- Behavioral: Cigarette flavor unrestricted and e-cigarette flavor unrestricted
Detailed Description
This study uses a mixed design (within-subject repeated measures and between-group).
Participants will be assigned to two different groups according to their preferred cigarette flavor (tobacco/menthol).
Every participant will complete behavioral tasks and make hypothetical purchases of tobacco products in an online store under four different scenarios: a) e-cigarette flavor restricted and cigarette flavor restricted, b) e-cigarette flavor unrestricted and cigarette flavor restricted, c) e-cigarette flavor restricted and cigarette flavor unrestricted, d) e-cigarette flavor unrestricted and cigarette flavor unrestricted.
Study Type
Interventional
Enrollment (Actual)
302
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Virginia
-
Roanoke, Virginia, United States, 24016
- Fralin Biomedical Research Institute
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
21 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- currently smoke at least 10 cigarettes per day
- have smoked at least 100 cigarettes (lifetime), and
- are 21 years of age or older.
Exclusion Criteria:
- inaccurate identification of usual brand of cigarette's as menthol or non-menthol
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Menthol cigarette smokers
Adults (21 y.o. and older) who smoke ate least 10 menthol cigarettes per day will be recruited.
|
|
|
Experimental: Non-menthol cigarette smokers
Adults (21 y.o. and older) who smoke ate least 10 non-menthol cigarettes per day will be recruited.
|
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Spent the Budget on E-cigarettes for Each Condition
Time Frame: 1 day
|
Participants will complete purchasing trials in an Experimental Tobacco Marketplace (ETM) with cigarettes increasing in price.
Product availability in the ETM depended on the experimental condition.
The average percentage of budget spent on e-cigarettes as a function of the restriction of cigarettes and/or e-cigarettes will be assessed.
|
1 day
|
|
Spent Budget on Cigarettes for Each Condition
Time Frame: 1 day
|
Participants will complete purchasing trials in an Experimental Tobacco Marketplace (ETM) with cigarettes increasing in price.
Product availability in the ETM depended on the experimental condition.
The average percentage of the budget spent on cigarettes as a function of the restriction of cigarettes and/or e-cigarettes will be assessed.
|
1 day
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Warren K Bickel, Ph.D., Fralin Biomedical Research Institute at VTC
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 26, 2021
Primary Completion (Actual)
August 13, 2021
Study Completion (Actual)
August 13, 2021
Study Registration Dates
First Submitted
October 11, 2021
First Submitted That Met QC Criteria
October 26, 2021
First Posted (Actual)
November 8, 2021
Study Record Updates
Last Update Posted (Estimated)
October 7, 2025
Last Update Submitted That Met QC Criteria
September 23, 2025
Last Verified
September 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- VT IRB# 20-827
- P01CA217806 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
The study team will share de-identified data upon request.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.